Chronic treatment with Δ9-tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction
- 31 July 2001
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 41 (1) , 118-129
- https://doi.org/10.1016/s0028-3908(01)00039-9
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Reversal of Dopamine D2Receptor Responses by an Anandamide Transport InhibitorJournal of Neuroscience, 2000
- Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaineEuropean Journal of Pharmacology, 1998
- Involvement of central cannabinoid (CB 1 ) receptors in the establishment of place conditioning in ratsPsychopharmacology, 1998
- Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716AEuropean Journal of Pharmacology, 1995
- THC does not affect striatal dopamine release: Microdialysis in freely moving ratsPharmacology Biochemistry and Behavior, 1991
- Δ9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysisPsychopharmacology, 1990
- Regional brain homovanillic acid followingδ9-tetrahydrocannabinol and cocaineBrain Research, 1986
- Evaluation of a suspension system for intravenous self-administration studies of water-insoluble compounds in the rhesus monkeyPharmacology Biochemistry and Behavior, 1977
- Tolerance to the effects of ? 9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activityPsychopharmacology, 1975
- Potentiation of Amphetamine-induced Arousal by StarvationNature, 1971